Loading...
Guest User
Welcome! Please login.
| IPO Listing At | BSE SME |
| SME IPO Issue Type | Book Build Issue |
| Total Issue Size | ₹26.94 Cr |
| Reserved for Market Maker | ₹0.00 Cr |
| Net Issue Size | ₹26.94 Cr |
| Fresh Issue | ₹25.58 Cr |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹51.00-52.00 per share |
| Discount | Retail: 0.00 |
| BSE Code | 543943 |
| Registrar | Cameo Corporate Services Ltd. |
| Lead Managers | Hem Securities Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 2,000 shares and in multiples thereof
Incorporated in 2005, Asarfi Hospital Limited provides healthcare facilities to the people of Jharkhand. The company was started by Nayan Prakash Singh and Harendra Singh in the name of their mother Asarfi Devi.
Asarfi Hospital is a 250 bedded multi-specialty hospital offering healthcare facilities to people for nearly two decades in Dhanbad, Jharkhand. The entity is Accredited by National Accreditation Board for Testing and Calibration Laboratories (NABL Accredited).
Asarfi Hospital operates with a dedicated team of doctors who are committed to offering their expert discretion and skills. As an integrated healthcare service provider, the company is committed towards delivering valued healthcare services to patients that include prevention, treatment, and proper rehabilitation.
To further the operations of the hospital, they are impaneled with several Government Agencies, Insurance and TPA providers, and Corporate Organizations for providing regular healthcare facilities to their employees.
Asarfi Hospital Limited has departments like Cardiology, General Medicine, Day Care Services, Paediatrics & Neonatology, Obstetrics & Gynaecology, Neurosciences, General Surgery, Gastroenterology, Pulmonology, Orthopaedics Plastic Surgery & Cosmetics, Nutrition & Dietetics, Oncology, Urology, Ophthalmology, Radiology, ENT, Dental, Nephrology, Physiotherapy, Emergency, Anaesthesiology & Critical Care, Pain Management and so on.
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Part Funding of Capital Expenditure of Cancer Hospital at Ranguni, Jharkhand. | 12.22 |
| 2 | Acquiring Land on Leasehold basis for Health Management and Research Institute at Ranchi, Jharkhand | 7.65 |
| 3 | General corporate purposes | 3.23 |
| Period Ended | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|
| Assets | 93.43 | 62.70 | 37.29 |
| Total Income | 73.03 | 66.20 | 54.40 |
| Profit After Tax | 8.02 | 5.73 | 3.53 |
| NET Worth | 41.84 | 22.63 | 16.90 |
| Reserves and Surplus | 27.35 | 21.38 | 15.65 |
| Total Borrowing | 17.20 | 11.63 | 7.13 |
| Amount in ₹ Crore | |||
| KPI | |
|---|---|
| ROE | 19.16% |
| ROCE | 19.91% |
| Debt / Equity | 0.41% |
| RoNW | 19.16% |
| PAT Margin | 11.34% |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 7.58 | |
| P/E (x) | 12.78 | |
| Promoter Holding | 83.03% | 61.17% |
| Market Cap | ₹102.32 Cr. | |
